Cite
APA Citation
Johansson, E. C., Hartz, S., Kiri, S. H., Kumar, G., & Svedbom, A. (2018). cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK. Journal of medical economics, 21, 810–820. http://access.bl.uk/ark:/81055/vdc_100066542579.0x000030